Join to access to all OVN content. Join for Free

Results for 'drug therapy'

How Cross-Functional Teams Reshape Cancer Care
OVN Avatar Kirk Shepard
How Cross-Functional Teams Reshape Cancer Care

Jay Fine, Preclinical Research, Early Stage

In episode 3 of Oncology Voice Network Podcast, Dr. Kirk Shepard sits down with Dr. Jay Fine, a renowned immunologist and President of R&D at Evolve Immune Therapeutics and a Forbes-published author in Voices of Oncology, for a candid look at how discovery truly connects to patient care.

Feb 17th • 23 mins listen

Aspiring MSL Insight: What Types of MSL Presentations are Acceptable in a Final Interview?
Partner Avatar Michael Pietrack
Aspiring MSL Insight: What Types of MSL Presentations are Acceptable in a Final Interview?

Aspiring MSL Insight: What Types of MSL Presentations are Acceptable in a Final Interview? 🧑‍⚕️🎤 If you’re an Aspiring MSL, you likely realize how important the MSL presentation is during the final interview. But you may be wondering, “What type of presentation should…

Aug 9th • 3 mins listen

Oncology Pharmacology 2023: Today’s Treatments and Tomorrow’s Breakthroughs
OVN Avatar The Oncology Nursing Podcast
Oncology Pharmacology 2023: Today’s Treatments and Tomorrow’s Breakthroughs

CDER, FDA, Nurses, biomarker, immunomodulatory

Highlights From Today’s Episode “Full approval through the Center for Drug Evaluation and Research (CDER) and FDA means that those drugs have gone through the laboratory testing, human clinical trial testing, and very extensive clinical trials to make sure that they are effective and th…

Mar 30th • 53 mins listen

Related Topics

Meet Our Innovation Partners

Loading partners...